Updated:
QHSLab, Inc.
QHSLab, Inc. is a healthcare technology company developing digital diagnostic platforms for primary care, not a family office or asset manager.
QHSLab, Inc.
QHSLab, Inc. is a publicly traded healthcare technology firm, not a family office or asset manager. Its core offering is a hardware-software platform that connects rapid diagnostic devices to electronic health record systems, enabling real-time data capture during patient visits. The company focuses on value-based care models, providing analytics to help clinicians manage chronic conditions. The company's strategy centers on recurring software subscriptions tied to its diagnostic hardware, with revenue streams from device placements and per-test fees. It operates primarily in the United States, targeting independent primary care practices and small-to-mid-sized clinics. As of public filings, QHSLab has not disclosed proprietary portfolio investments or third-party capital under management. With fewer than 20 employees based on public filings, QHSLab maintains a lean operational structure. Its business model does not involve typical investment or wealth management functions. No philanthropic vehicles or adjacent investment arms are publicly associated with the firm. QHSLab's structural differentiator is its focus on integrating point-of-care diagnostics directly into clinical workflows through EHR connectivity, a niche that differentiates it from broader health IT platforms. The firm operates as an operating company rather than an allocator of capital, making it structurally distinct from family offices or asset managers.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
—
Country
—
City
—
Corporate office
—
Frequently asked questions
Who runs investment decisions at QHSLab, Inc.?
QHSLab, Inc. is a publicly traded operating company, not an investment firm. Investment decisions are made by its board of directors and executive team, which include the CEO and CFO. The company does not manage third-party capital or run a family office structure.
How does QHSLab source proprietary deal flow?
QHSLab does not engage in deal sourcing typical of asset managers. It operates as a medical device and software company, developing its own technology through internal R&D. Any partnerships or acquisitions would be disclosed in SEC filings.
Is QHSLab structured as a single family office or does it operate more like a venture firm?
QHSLab is neither a family office nor a venture firm. It is a publicly traded healthcare technology company registered with the SEC. Its structure is corporate, with shareholders and a board, not a wealth management vehicle for a single family.
Does QHSLab participate in fund commitments or only direct deals?
Based on public records, QHSLab does not participate in fund commitments or direct institutional investment deals. Its operations are limited to its own product development and sales activities.
What investment stages does QHSLab typically target?
QHSLab is not an investor in external companies. It focuses on developing and commercializing its own diagnostic platform, targeting early-stage commercialization for the primary care market. It does not target investment stages.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: